Medios AGMEDOF 88 Return-on-Tangible-Asset is 4.60% as of Mar. 2026, which is 12% below its 10-year median of 5.21. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $70.33. The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, Medios AG ranks better than 58.47% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Medios AG's annualizedNet Income for the quarter that ended in Mar. 2026 was $23 Mil. Medios AG's average total tangible assets for the quarter that ended in Mar. 2026 was $499 Mil. Therefore, Medios AG's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 4.60%.
The historical rank and industry rank for Medios AG's Return-on-Tangible-Asset or its related term are showing as below:
MEDOF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -13.99 Med: 5.21 Max: 12.83
Current: 3.24
During the past 13 years, Medios AG's highest Return-on-Tangible-Asset was 12.83%. The lowest was -13.99%. And the median was 5.21%.
MEDOF's Return-on-Tangible-Asset is ranked better than 58.47% of 118
companies
in the Medical Distribution industry
Industry Median: 2.305
vs MEDOF: 3.24
Medios AG (OTCPK:MEDOF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Medios AG Return-on-Tangible-Asset Related Terms
Medios AG Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Medios AG's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDOF vs MCK, CAH, COR: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, Medios AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Medios AG's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 4.60% mean?
Medios AG (MEDOF) has a Return-on-Tangible-Asset of 4.60% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Medios AG and its competitors. This is 12% below median its historical median of 5.21. According to the industry distribution chart, Medios AG ranks #49 out of 118 companies in the Medical Distribution industry, placing it in the top 41.5%.
Is Medios AG's Return-on-Tangible-Asset too high?
Medios AG's current Return-on-Tangible-Asset of 4.60% is 12% below median its 10-year median of 5.21. The Medical Distribution industry median Return-on-Tangible-Asset is 2.31. Medios AG's value of 4.60% is 99.6% above this industry median. Based on the distribution chart, Medios AG ranks #49 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's Return-on-Tangible-Asset compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medios AG ranks #49 out of 118 companies for Return-on-Tangible-Asset. This puts Medios AG in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.31. Medios AG's value of 4.60% is 99.6% above this benchmark. While the company's 10-year median is 5.21 vs. the industry median of 2.31, Medios AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.31, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current Return-on-Tangible-Asset of 4.60% is 99.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current Return-on-Tangible-Asset is 4.60%, which is 12% below median its own 10-year median of 5.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current Return-on-Tangible-Asset of 4.60%. The stock's GF Value™ is $70.33, compared to a current price of $50.00 — trading 28.9% below its estimated fair value. The current Return-on-Tangible-Asset is 4.60%, which is 12% below median its 10-year median of 5.21 and 99.6% above the Medical Distribution industry median of 2.31. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Medios AG (MEDOF), the current Return-on-Tangible-Asset is 4.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (MEDOF) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of $50.00 is trading 28.9% below its estimated GF Value™ of $70.33.
Key valuation signals for MEDOF:
Return-on-Tangible-Asset: 4.60% (12% below median its 10-year median of 5.21)
GF Value™: $70.33 vs. price of $50.00 (28.9% below fair value)
Industry Position: 99.6% above the Medical Distribution median (#49 of 118)
No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for MEDOF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDOF has been successfully added to your 
